4 free views remaining today
cone dystrophy
ICD-10 Codes
Related ICD-10:
Description
Cone Dystrophy: A Progressive Vision Disorder
Cone dystrophy is a rare genetic eye disorder that affects the cone cells in the retina, leading to progressive loss of central and color vision [1]. This condition typically appears in the first two decades of life and can cause significant visual impairment if left untreated.
The symptoms of cone dystrophy may include:
- Central vision loss: Difficulty seeing objects or people directly in front of you
- Color vision disturbances: Trouble distinguishing between different colors
- Blurred vision: Objects appear fuzzy or unclear
As the condition progresses, individuals with cone dystrophy may experience a gradual decline in their visual acuity and color perception [2]. In severe cases, cone dystrophy can lead to blindness.
Causes and Risk Factors
Cone dystrophy is an inherited condition, meaning it is passed down from parents to children through genetic mutations. The exact cause of the disorder is not fully understood, but research suggests that it is related to changes in one of the 35 genes identified so far [3].
References:
[1] Cone-rod dystrophy (CRD) is a group of inherited eye disorders that affect the light sensitive cells of the retina called the cones and rods. [Context #2]
[2] A rare genetic isolated inherited retinal disorder characterized by primary cone degeneration with significant secondary rod involvement. [Context #5]
[3] Nov 30, 2020 — Cone dystrophy and cone-rod dystrophy describe a group of inherited retinal dystrophies caused by genetic changes in one of the 35 genes identified so far. [Context #7]
Additional Characteristics
- Cone dystrophy is a rare genetic eye disorder that affects the cone cells in the retina, leading to progressive loss of central and color vision.
- The symptoms of cone dystrophy may include: Central vision loss, Color vision disturbances, Blurred vision
- As the condition progresses, individuals with cone dystrophy may experience a gradual decline in their visual acuity and color perception.
- Cone dystrophy is an inherited condition, meaning it is passed down from parents to children through genetic mutations.
Signs and Symptoms
Cone dystrophy is a rare genetic disorder that affects the retina, leading to progressive vision loss. The signs and symptoms of cone dystrophy can vary from person to person, but here are some common ones:
- Decreased visual clarity (acuity): People with cone dystrophy may experience difficulty seeing objects clearly, even at close range [1].
- Color perception problems: Cone dystrophy can cause difficulties in perceiving colors, which is known as dyschromatopsia [1].
- Night blindness: As the condition progresses, individuals may develop night blindness, making it difficult to see in low light conditions [3].
- Peripheral vision loss: Over time, cone dystrophy can lead to a worsening of peripheral vision, which can limit independent mobility [3].
- Nystagmus (involuntary eye movements): Some people with cone dystrophy may experience involuntary movements of the eyes [4].
- Extreme short-sightedness: Cone dystrophy can cause extreme near-sightedness, requiring glasses to improve vision [4].
- Central scotoma: A central scotoma is a blind spot in the center of the visual field, which can be a symptom of cone dystrophy [5].
- Photophobia (sensitivity to light): People with cone dystrophy may experience sensitivity to light and discomfort when exposed to bright lights [6].
It's essential to note that these symptoms can develop gradually over time, and early detection is crucial for proper management and treatment.
Additional Symptoms
- Central scotoma
- Night blindness
- Photophobia (sensitivity to light)
- Nystagmus (involuntary eye movements)
- Decreased visual clarity (acuity)
- Color perception problems
- Peripheral vision loss
- Extreme short-sightedness
Diagnostic Tests
Cone dystrophy, a rare genetic disorder affecting the retina, can be diagnosed through various diagnostic tests. Here are some of the key tests used to diagnose cone dystrophy:
- Electroretinography (ERG): This is a special ophthalmic electrophysiology test that measures the electrical activity of the retina in response to light stimulation. It is considered the main test for diagnosing cone dystrophy [1].
- Visual Evoked Potential (VEP) tests: These tests measure the electrical signals produced by the brain's visual cortex in response to visual stimuli. They can help diagnose eye diseases, including cone dystrophy [6].
- Fundus examination and autofluorescence imaging: A thorough examination of the retina using a specialized camera can reveal signs of cone dystrophy, such as changes in the retinal pigment epithelium.
- Optical Coherence Tomography (OCT): This non-invasive imaging test uses low-coherence interferometry to produce high-resolution images of the retina. It can help identify structural changes associated with cone dystrophy [5].
- Genetic testing: Genetic testing for cone-rod dystrophy can establish or confirm the diagnosis, identify risks for additional related symptoms, and provide information on carrier status for at-risk family members [8].
These diagnostic tests are essential in confirming a diagnosis of cone dystrophy and ruling out other conditions that may present similar symptoms.
References:
[1] While those methods are helpful, the main test to diagnose cone-rod dystrophy is a special ophthalmic electrophysiology test called electroretinography. This ...
[5] The diagnosis of CRD is based on clinical history, fundus examination, autofluorescence imaging, optical coherence tomography and full field electroretinogram.
[6] Feb 11, 2022 — visual electrophysiology — ERG and visual evoked potential (VEP) tests — can help diagnose eye disease ...
[8] Genetic testing for cone-rod dystrophy can: Establish or confirm the appropriate diagnosis; Identify risks for additional related symptoms; Result in more ...
Additional Diagnostic Tests
- Optical Coherence Tomography (OCT)
- Genetic testing
- Electroretinography (ERG)
- Visual Evoked Potential (VEP) tests
- Fundus examination and autofluorescence imaging
Treatment
Current Status of Drug Treatment for Cone Dystrophy
Unfortunately, there are no proven treatments for Cone-Rod Dystrophies as of yet [4]. However, recent years have noted advances in clinical research and development. Maximizing an individual's remaining vision is the primary goal of treatment.
Emerging Therapies
- Gene therapy has shown promise in treating cone dystrophy. A study using an adeno-associated virus serotype 8 (AAV8) to deliver a gene that counteracts degeneration of cone photoreceptors was conducted [5].
- Another study found that SPVN06, a gene therapy, had a manageable safety profile in patients with rod-cone dystrophy (RCD) [8].
Other Considerations
While there is no treatment for cone dystrophy, certain diagnostic tools can help facilitate diagnosis in early stages. These include fluorescent angiography, ERG, and color vision tests [9].
Recommended Medications
- Gene therapy
- SPVN06 (gene therapy)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Cone Dystrophy
Cone dystrophy, a rare inherited eye disorder, requires careful differential diagnosis to distinguish it from other macular dystrophies and hereditary optic atrophies. The following conditions are often considered in the differential diagnosis:
- Other hereditary cone disorders: Achromatopsia and allied cone dysfunction syndromes, cone dystrophy,
Additional Differential Diagnoses
- cone dystrophy
- retinal cone dystrophy 3A
- retinitis pigmentosa 7
- retinitis pigmentosa 10
- retinitis pigmentosa 24
- cone-rod dystrophy 2
- X-linked cone-rod dystrophy 3
- cone-rod dystrophy 6
- cone-rod dystrophy 10
- cone-rod dystrophy 17
- obsolete congenital nystagmus 4
- obsolete color vision defect
- achromatopsia 2
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_831
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_5679
- owl#annotatedSource
- t332734
- relatedICD
- http://example.org/icd10/H21.272
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#created_by
- lschriml
- oboInOwl#creation_date
- 2013-11-12T01:19:22Z
- oboInOwl#id
- DOID:0050795
- oboInOwl#hasDbXref
- MESH:D000077765
- IAO_0000115
- A retinal disease that is characterized by the loss of cone cells, the photoreceptors responsible for both central and color vision.
- oboInOwl#hasExactSynonym
- retinal cone dystrophy
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- core#notation
- DOID:0050795
- core#exactMatch
- MESH:D000077765
- rdf-schema#label
- cone dystrophy
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.